Trends shaping GLP-1 landscape include FDA regulatory updates, rapid oral drug adoption, and shifting clinical evidence for diabetes care.

Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few ...

The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it.

Brooke Boyarsky Pratt, CEO, and Dr. Angela Fitch, chief medical officer, are both co-founders of knownwell. More than 12% of U.S. adults now take a GLP-1 medication, marking one of the ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

GLP-1 medications have reached a level of household penetration that food and beverage brands can no longer ignore, but the impact on grocery sales is unfolding more gradually than some might expect.

A comprehensive meta-analysis of 91 clinical trials involving more than 100,000 patients showed no increased risk for suicidal ideation or other psychiatric adverse events with GLP-1 receptor agonist ...

More people are paying out-of-pocket for GLP-1 weight loss drugs — and more retailers are offering discounts on Zepbound, Ozempic, and Wegovy. Walmart will offer in-store pickup for Zepbound at ...

GLP-1 drugs have rapidly shifted from niche diabetes treatments to blockbuster weight loss injections, reshaping everything from cardiology guidelines to grocery bills. As prescriptions soar, a ...

At Lifesum, we help organizations like Amazon, PayPal and GE, turn appetite changes into lasting habits through personalized ...

The market for GLP 1 companion foods in Asia faces some major challenges – but big opportunities also await if played right ...

Interview insights explain how GLP-1R agonists access brain regions governing reward, motivation, and stress. Animal studies ...